DKN-01
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for DKN-01, covering 2016-09-28 to 2026-02-11. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer [Phase 2]